<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24799" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>McCune-Albright Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Holbrook</surname>
            <given-names>Leilani</given-names>
          </name>
          <aff>SAUSHEC, JBSA San Antonio</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Brady</surname>
            <given-names>Robert</given-names>
          </name>
          <aff>Uniformed Services University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Leilani Holbrook declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Robert Brady declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24799.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>McCune-Albright syndrome is a rare genetic disordered originally recognized by the triad of polyostotic fibrous dysplasia, precocious puberty, and cafe-au-late spots. A variety of endocrine disorders, including hyperthyroidism, acromegaly, phosphate wasting, and Cushing syndrome are now considered as part of the endocrinopathies seen in this disorder. The variable constellation of symptoms arises from a somatic activating mutation of the GNAS gene, which is present in many tissue types. This activity reviews the etiology, presentation, evaluation, and management of McCune-Albright syndrome and reviews the role of the interprofessional team in evaluating, diagnosing, and managing the condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of McCune-Albright syndrome.</p></list-item><list-item><p>Explain the examination and evaluation strategies necessary to diagnose McCune-Albright syndrome.</p></list-item><list-item><p>Summarize the treatment and management options available for McCune-Albright syndrome</p></list-item><list-item><p>Review the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by McCune-Albright syndrome</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24799&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24799">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24799.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>McCune-Albright syndrome is a rare genetic disordered originally recognized by the triad of polyostotic fibrous dysplasia, precocious puberty, and caf&#x000e9;-au-lait spots. A&#x000a0;variety of endocrine disorders, including hyperthyroidism, acromegaly, phosphate wasting, and Cushing syndrome are now considered as part of the endocrinopathies seen in this disorder. The variable constellation of symptoms arises from a somatic activating mutation of the GNAS gene, which is present in many tissue types.<xref ref-type="bibr" rid="article-24799.r1">[1]</xref></p>
      </sec>
      <sec id="article-24799.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The cause of McCune-Albright syndrome is a spontaneous post zygotic missense mutation at ARG201 or Gln227 of the GNAS gene during embryogenesis. GNAS encodes the alpha subunit&#x000a0;portion of a G-signaling complex that&#x000a0;found in multiple tissue types, including bone, skin, and endocrine tissues.&#x000a0;&#x000a0;The mutation is distributed in a mosaic pattern and presenting signs and symptoms are dependent&#x000a0;on the time frame the mutation occurs.&#x000a0; Mutated GNAS results in a constitutively active alpha subunit,&#x000a0;causing increased intracellular cAMP, and mediating the action of downstream hormones.<xref ref-type="bibr" rid="article-24799.r2">[2]</xref></p>
      </sec>
      <sec id="article-24799.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of McCune-Albright syndrome is estimated to be between 1 in 100,000 to 1 in 1,000,000.<xref ref-type="bibr" rid="article-24799.r1">[1]</xref></p>
      </sec>
      <sec id="article-24799.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>An increase in intracellular cAMP signaling is responsible for the clinical manifestations of McCune-Albright syndrome. The phenotype is dependent on which tissue types the mutation occurs.<xref ref-type="bibr" rid="article-24799.r2">[2]</xref>&#x000a0; In bone, increased cAMP causes osteoblasts&#x000a0;to differentiate into stromal cells while inhibiting further differentiation, resulting in fibrous dysplasia. These fibrous dysplastic lesions then exhibit increased secretion of phosphaturic hormone fibroblastic growth factor-23 (FGF23),&#x000a0;causing&#x000a0;renal phosphate wasting.<xref ref-type="bibr" rid="article-24799.r3">[3]</xref>&#x000a0; Increased cAMP signaling in the skin results in stimulation of melanin production via alpha-MSH, resulting in caf&#x000e9;-au-lait macules. Increased cAMP in endocrine tissue&#x000a0;results in increased production and secretion of a specific hormone product.&#x000a0; Affected&#x000a0;endocrine tissues can include the gonads, thyroid, pituitary, parathyroid, and adrenal glands.<xref ref-type="bibr" rid="article-24799.r1">[1]</xref></p>
      </sec>
      <sec id="article-24799.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Characteristics of fibrous dysplasia include an increased number of thin and irregular trabeculae.&#x000a0;The marrow spaces get replaced by fibroblastic tissue.&#x000a0; Lesions may be monostotic (involving one bone) or polyostotic (multiple bones involved). Commonly identified by radiograph, fibrodysplasia&#x000a0;shows a hazy, radiolucent, ground-glass pattern due to defective mineralization.<xref ref-type="bibr" rid="article-24799.r3">[3]</xref></p>
      </sec>
      <sec id="article-24799.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Initial clinical presentation is typically due to either precocious puberty or symptoms related to fibrous dysplasia.&#x000a0; Females can present with vaginal bleeding and development of breast tissue. Males can present with testicular enlargement, appearance pubic and axillary hair, and increased body odor. Caf&#x000e9;-au-lait spots may be appreciated in retrospect unless they are prominent.&#x000a0; These spots are typically midline and described as having &#x0201c;coast of Maine&#x0201d; jagged borders.<xref ref-type="bibr" rid="article-24799.r1">[1]</xref></p>
        <p>Fibrous dysplastic lesions&#x000a0;can present&#x000a0;as a pathologic fracture or pain.&#x000a0; Lesions of the calvarium and facial bones are common and can present as painless facial asymmetry. Radiographs reveal a characteristic lesion of thinning cortex and intramedullary &#x0201c;ground glass.&#x0201d;<xref ref-type="bibr" rid="article-24799.r4">[4]</xref></p>
        <p>Symptoms of endocrinopathies are specific to the&#x000a0;affected organ. Hyperthyroidism is common. Growth hormone and prolactin secretion present as acromegaly and disruption of normal gonadal function. Cushing syndrome is typically adrenal,&#x000a0;presents in the neonatal period and is most commonly transient.<xref ref-type="bibr" rid="article-24799.r1">[1]</xref></p>
      </sec>
      <sec id="article-24799.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>McCune-Albright syndrome is largely a clinical diagnosis. Genetic testing for GNAS mutation is commercially available, however, due to the mosaicism, false negatives do&#x000a0;occur, and a positive result contributes little to the clinical management.<xref ref-type="bibr" rid="article-24799.r2">[2]</xref></p>
        <p>Evaluation includes radiographs or computed tomography (CT) to identify and characterize fibrodysplastic lesions. In early childhood, patients with McCune-Albright syndrome are more likely to experience stress fractures that may lead to permanent deformity&#x000a0;if not stabilized. CT scan of the skull helps in the&#x000a0;diagnosis of craniofacial bone lesions and pituitary lesions. Regular vision and hearing tests can monitor lesions affecting those systems. &#x000a0;Baseline bone scan with 99Tc-methyl diphosphate&#x000a0;is&#x000a0;indicated in endocrinopathies that affect bone development.<xref ref-type="bibr" rid="article-24799.r5">[5]</xref></p>
        <p>Precocious puberty in McCune-Albright syndrome is typically peripheral and due to activation of ovarian or testicular tissue. Evaluation includes serum estradiol and testosterone levels. Boys should have a testicular ultrasound to assess for hormonally active tumors.&#x000a0; High levels of estradiol in girls may cause activation of hypothalamic-pituitary-gonadal axis, triggering&#x000a0;evaluation for central precocious puberty. Additionally, GnRH stimulation testing and serum measurements of luteinizing hormone and follicle-stimulating hormone may be warranted.<xref ref-type="bibr" rid="article-24799.r6">[6]</xref></p>
        <p>Evaluation for growth hormone excess includes oral glucose tolerance test and serum growth hormone and prolactin measurements.&#x000a0; Evaluation of hyperthyroidism includes measurement of thyroid-stimulating hormone (TSH), free and bound thyroxine, and T3. Periodic ultrasound is recommended with an appropriate follow-up of any abnormal findings. Monitoring levels&#x000a0;of serum phosphate and&#x000a0;renal&#x000a0;reabsorption of phosphate is also a recommendation.<xref ref-type="bibr" rid="article-24799.r7">[7]</xref><xref ref-type="bibr" rid="article-24799.r8">[8]</xref></p>
      </sec>
      <sec id="article-24799.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The mainstay treatment of gonadotropin-independent precocious puberty is aromatase inhibitors and more recently tamoxifen in females. In the case of the development of central precocious puberty, steady-state gonadotropin-releasing hormone analogs are used to downregulate hypothalamic-pituitary-gonadal axis.<xref ref-type="bibr" rid="article-24799.r9">[9]</xref><xref ref-type="bibr" rid="article-24799.r10">[10]</xref><xref ref-type="bibr" rid="article-24799.r11">[11]</xref></p>
        <p>Treatment of hyperthyroidism is initially managed medically with antithyroid medications and radioablation. &#x000a0;Growth hormone excess treatment is by somatostatin or direct GH receptor antagonists. Hyperprolactinemia management is with bromocriptine.&#x000a0; In patients with demonstrated pituitary adenomas, surgical resection of the adenoma is an option.&#x000a0; Treatment of hypophosphatemia with oral supplementation&#x000a0;is under debate, but supplementation should be used in the setting of rickets.<xref ref-type="bibr" rid="article-24799.r7">[7]</xref><xref ref-type="bibr" rid="article-24799.r8">[8]</xref></p>
        <p>No definitive guidelines for surgical intervention of fibrous dysplastic lesions exist. However, common indications for surgical stabilization include progression of pain, stress fracture, deformity, or loss of function. The data for prophylactic surgery are lacking. Studies investigating the use of high dose bisphosphonates show mixed results, and currently,&#x000a0;the only indication for bisphosphonate therapy is pain relief. Surgical intervention&#x000a0;due to&#x000a0;cranial-facial lesions may be necessary when there is a potential for loss or sight or hearing.&#x000a0;</p>
      </sec>
      <sec id="article-24799.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Neurofibromatosis and McCune-Albright syndrome both can present with&#x000a0;caf&#x000e9;-au-lait macules. The caf&#x000e9;-au-lait macules of neurofibromatosis typically have smooth borders,&#x000a0; while the macules of McCune-Albright are midline and have&#x000a0;a jagged&#x000a0;or irregular appearance.&#x000a0; Additionally, neurofibromatosis characteristically presents with neurofibromas, which are lacking in McCune-Albright syndrome.<xref ref-type="bibr" rid="article-24799.r1">[1]</xref></p>
        <p>Fibrous dysplasia is&#x000a0;common as an isolated finding&#x000a0;of single or multiple lesions.&#x000a0; While some&#x000a0;lesions are&#x000a0;caused by the same GNAS mutation as McCune-Albright, in the absence of endocrinopathy and caf&#x000e9;-au-lait macules, the diagnosis of isolated fibrous dysplasia is more likely.<xref ref-type="bibr" rid="article-24799.r2">[2]</xref></p>
        <p>Precocious puberty may be central or peripheral and in females is often idiopathic. Hormonally active tumors and congenital adrenal hyperplasia are other diagnostic considerations in patients presenting with precocious puberty. Patients presenting with precocious puberty should undergo skeletal survey to rule out McCune-Albright syndrome.<xref ref-type="bibr" rid="article-24799.r6">[6]</xref></p>
      </sec>
      <sec id="article-24799.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis may be challenging to ascertain due to the&#x000a0;varying severity of the disease. Younger patients with&#x000a0;renal phosphate wasting and&#x000a0;polyostotic lesions have a higher risk of clinically relevant bone pain and fracture.<xref ref-type="bibr" rid="article-24799.r12">[12]</xref></p>
        <p>The primary treatment goal of precocious puberty is the preservation of potential adult height. Without intervention, growth plates&#x000a0;close prematurely resulting in short&#x000a0;stature.<xref ref-type="bibr" rid="article-24799.r9">[9]</xref></p>
        <p>While rare, there is potential for malignant transformation of fibrous dysplastic lesions.<xref ref-type="bibr" rid="article-24799.r3">[3]</xref> There are also reports of increased breast cancer risk.<xref ref-type="bibr" rid="article-24799.r1">[1]</xref></p>
      </sec>
      <sec id="article-24799.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Possible complications include pain and fracture at sites of fibrous dysplastic lesions.&#x000a0; Because of phosphate wasting, there is an increased risk of developing rickets.</p>
        <p>Decreased adult stature is the main complication of untreated precocious puberty.<xref ref-type="bibr" rid="article-24799.r6">[6]</xref></p>
      </sec>
      <sec id="article-24799.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients and parents should receive counseling that the cause of McCune-Albright syndrome a spontaneous mutation and is not vertically transmittable to offspring.<xref ref-type="bibr" rid="article-24799.r1">[1]</xref> Due to the wide variety of endocrinopathies, patients should receive close follow up with measurement of bone maturity and hormone levels.&#x000a0;</p>
      </sec>
      <sec id="article-24799.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Given the wide variety of manifestations, many key specialists may be involved in patient care, including but not limited to pediatric orthopedic surgery, pediatric endocrinology, and physical therapy. Personalized care coordination is vital between pediatricians and pediatric nursing who need to maintain a high index of suspicion in recognizing endocrinopathies and pathologic fractures in McCune-Albright syndrome.&#x000a0;</p>
      </sec>
      <sec id="article-24799.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24799&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24799">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/mccune-albright-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24799">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24799/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24799">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-24799.s16">
        <fig id="article-24799.image.f1" position="float" orientation="portrait">
          <caption>
            <p>McCune AlBright Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="McCune__Albright" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-24799.s17">
        <title>References</title>
        <ref id="article-24799.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dumitrescu</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>McCune-Albright syndrome.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2008</year>
            <month>May</month>
            <day>19</day>
            <volume>3</volume>
            <fpage>12</fpage>
            <pub-id pub-id-type="pmid">18489744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24799.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bastepe</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>GNAS Spectrum of Disorders.</article-title>
            <source>Curr Osteoporos Rep</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>146</fpage>
            <page-range>146-58</page-range>
            <pub-id pub-id-type="pmid">25851935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24799.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leet</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Current approach to fibrous dysplasia of bone and McCune-Albright syndrome.</article-title>
            <source>J Child Orthop</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-17</page-range>
            <pub-id pub-id-type="pmid">19308500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24799.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Belsuzarri</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Araujo</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Melro</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Neves</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Navarro</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Brito</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Pontelli</surname>
                <given-names>LO</given-names>
              </name>
              <name>
                <surname>de Abreu Mattos</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Gon&#x000e7;ales</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Zeviani</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>McCune-Albright syndrome with craniofacial dysplasia: Clinical review and surgical management.</article-title>
            <source>Surg Neurol Int</source>
            <year>2016</year>
            <volume>7</volume>
            <issue>Suppl 6</issue>
            <fpage>S165</fpage>
            <page-range>S165-9</page-range>
            <pub-id pub-id-type="pmid">27057395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24799.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leet</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Chebli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kushner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Brillante</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Robey</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Bianco</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wientroub</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.</article-title>
            <source>J Bone Miner Res</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>571</fpage>
            <page-range>571-7</page-range>
            <pub-id pub-id-type="pmid">15005844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24799.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bercaw-Pratt</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Moorjani</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>XM</given-names>
              </name>
              <name>
                <surname>Karaviti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dietrich</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review.</article-title>
            <source>J Pediatr Adolesc Gynecol</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>e9</fpage>
            <page-range>e9-e13</page-range>
            <pub-id pub-id-type="pmid">22051789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24799.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shetty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Varghese</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Shanthly</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>TV</given-names>
              </name>
            </person-group>
            <article-title>Toxic Thyroid Adenoma in McCune-Albright Syndrome.</article-title>
            <source>J Clin Diagn Res</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>281</fpage>
            <page-range>281-2</page-range>
            <pub-id pub-id-type="pmid">24701557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24799.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chakraborty</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Kashyap</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Manohar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhansali</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Radioiodine treatment in McCune-Albright syndrome with hyperthyroidism.</article-title>
            <source>Indian J Endocrinol Metab</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>654</fpage>
            <page-range>654-6</page-range>
            <pub-id pub-id-type="pmid">22837937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24799.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eugster</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Central Precocious Puberty: Update on Diagnosis and Treatment.</article-title>
            <source>Paediatr Drugs</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>273</fpage>
            <page-range>273-81</page-range>
            <pub-id pub-id-type="pmid">25911294</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24799.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Estrada</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Brillante</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Guthrie</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Gafni</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>175</volume>
            <issue>5</issue>
            <fpage>477</fpage>
            <page-range>477-483</page-range>
            <pub-id pub-id-type="pmid">27562402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24799.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de G Buff Passone</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kuperman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cabral de Menezes-Filho</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Spassapan Oliveira Esteves</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lana Obata Giroto</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Damiani</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Tamoxifen Improves Final Height Prediction in Girls with McCune-Albright Syndrome: A Long Follow-Up.</article-title>
            <source>Horm Res Paediatr</source>
            <year>2015</year>
            <volume>84</volume>
            <issue>3</issue>
            <fpage>184</fpage>
            <page-range>184-9</page-range>
            <pub-id pub-id-type="pmid">26227563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24799.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benhamou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gensburger</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Messiaen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chapurlat</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Prognostic Factors From an Epidemiologic Evaluation of Fibrous Dysplasia of Bone in a Modern Cohort: The FRANCEDYS Study.</article-title>
            <source>J Bone Miner Res</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>12</issue>
            <fpage>2167</fpage>
            <page-range>2167-2172</page-range>
            <pub-id pub-id-type="pmid">27340799</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
